Oral Glycoprotein IIb/IIIa Inhibitors: Why Don't They Work?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.6, 2001-06, pp. : 421-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Oral glycoprotein IIb/IIIa antagonists unsuccessful

Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

By Liu F. Craft R.M. Morris S.A. Carroll R.C.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2673-2687

Informa Healthcare

Access to resources Recommend Favorite

Design and synthesis of a series of indole glycoprotein IIb/IIIa inhibitors

By Grumel V. Merour J.-Y. Lesur B. Giboulot T. Frydman A. Guillaumet G.

European Journal of Medicinal Chemistry, Vol. 37, Iss. 1, 2002-01 ,pp. : 45-62

Elsevier

Access to resources Recommend Favorite

The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

By Manoharan G. Maynard S.J. Adgey A.J.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 555-566

Informa Healthcare

Access to resources Recommend Favorite